Curt LaBelle
InvestorManaging Partner at Global Health Investment Fund · Venture Partner at Adjuvant Capital
New York
About
Curt LaBelle is a Venture Partner at Adjuvant Capital with over 16 years of experience investing in healthcare companies. He was previously a managing director at Tullis Health Investors and a vice president at Investor Growth Capital. He holds a BS in economics from Brigham Young University and both MD and MBA degrees from Columbia University.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- AXA IM Global Health Private EquityManaging Partnercurrent2022 — present
- AXA IM Prime Impact FundAdvisorcurrent2020 — present
- Novocuff, Inc.Board Membercurrent2024 — presentUnited States
- Vedanta Biosciences, Inc.Board Membercurrent2023 — presentCambridge, Massachusetts, United States
- Epion TherapeuticsBoard Membercurrent2022 — presentGreater Boston
- Maternal Newborn Health InnovationsBoard Membercurrent2022 — present
- Ophirex, Inc.Board Membercurrent2022 — presentSan Francisco Bay Area
- Z OpticsChair Of The Board Of Directorscurrent2020 — presentUnited States
- Atticus MedicalMember, Board of Directorscurrent2015 — present
- Serum InstituteChair, Steering Committee2017 — 2023Pune, India
- Atomo Diagnostics (ASX: AT1)Member, Board Of Directors2016 — 2023
- Global Health Investment FundManaging Partner2015 — 2023Greater New York City Area
- IanTech (acquired by Zeiss)Lead Investor, Head of Global Access Committee2015 — 2023
- Revelation Biosciences Inc.Board Member2021 — 2023
- Eyenovia (Nasdaq EYEN)Board Member2015 — 2022
- Alydia Health (acquired by Organon)Chair, Board Of Directors2018 — 2021
- SafeOp Surgical (acquired by Alphatec)Chair Of The Board Of Directors2011 — 2015Stamford, CT
- Exagen Inc. (Nasdaq XGN)Chair, Board of Directors2009 — 2015
- Tullis Health InvestorsManaging Director2008 — 2015Stamford, CT
- Estech (acquired by Atricure)Board Observer2010 — 2013San Francisco Bay Area
- Impulse Monitoring (sold to Nuvasive)Chair, Board of Directors, Shareholder Representative2008 — 2011Baltimore, Maryland Area
- Sirion TherapeuticsBoard of Directors2006 — 2008
- KAI Pharmaceuticals (sold to Amgen)Board of Directors2006 — 2008San Francisco Bay Area
- Investor Growth CapitalVice President2005 — 2008Greater New York City Area
- Tullis Health InvestorsSenior Associate2002 — 2005Greenwich, CT
Skills & more
Impact Investing1Venture FinancingGrowth CapitalOphthalmology
Languages English · Finnish
From Curt's professional profile.
Investments
Board seats
CoherexEstechExagen DiagnosticsImpulse MonitoringKAI PharmaceuticalsSafeOpSirion TherapeuticsTransMolecular
Per the firm's website.
Frequently asked questions
- Who is Curt LaBelle?
- Curt LaBelle is a Venture Partner at Adjuvant Capital with over 16 years of experience investing in healthcare companies. He was previously a managing director at Tullis Health Investors and a vice president at Investor Growth Capital. He holds a BS in economics from Brigham Young University and both MD and MBA degrees from Columbia University.
- Where does Curt LaBelle work?
- Curt LaBelle is Managing Partner at Global Health Investment Fund.
- What does Curt LaBelle invest in?
- Curt LaBelle invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Curt LaBelle sit on?
- Curt LaBelle holds tracked board seats at Coherex, Estech, Exagen Diagnostics, Impulse Monitoring, KAI Pharmaceuticals, SafeOp, Sirion Therapeutics, TransMolecular.
- Where did Curt LaBelle go to school?
- Curt LaBelle studied at Columbia Business School (MBA); Columbia University Vagelos College of Physicians and Surgeons (MD); Brigham Young University (Bachelor’s Degree, Economics).
Same school
Also attended Columbia Business School895
Steve JobsCo-founder of Apple, NeXT and PixarRyan PetersenFounder & CEO of FlexportAryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at Revolution
+ 889 more
Also attended Columbia University Vagelos College of Physicians and Surgeons24
Tristan HuntPartner at Averin CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesShreeram AradhyeInvestor at Novartis Venture FundJoseph MayerPartner at HLM Investment PartnersJoan LaRovereOperating Partner at iSelect FundStefano BiniHealth Moonshot Impact Board at StartUp Health
+ 18 more
Also attended Brigham Young University300
Jake StormDeal Partner at Felicis VenturesJen ArdManaging Director, Head of Investment Operations at Intel CapitalNathan MickelsenVice President of Tax at RevolutionJohn SabinChief Financial Officer; President, Revolution Places at RevolutionDiogo MyrrhaPartner at Peak VenturesSid KrommenhoekPartner at Album
+ 294 more
Shared employers
Also worked at Novocuff, Inc.1
Also worked at Ophirex, Inc.1
Also worked at Global Health Investment Fund4
Also worked at Tullis Health Investors10
John TullisManaging Partner at Tullis Health InvestorsKathrine KowalikDirector of Investor Relations at WAVE Equity PartnersSteven GindiChief Financial Officer at Tullis Health InvestorsDavid LeffellVenture Partner, MD at Tullis Health InvestorsDarlene FranzéVice President, Administration at Tullis Health InvestorsMelanie OldemanVice President, Investor Communications at Tullis Health Investors
+ 4 more




















.avif)













